ALPHARETTA, Ga., Feb. 13,
2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:
AVNS) will webcast its conference call discussing financial results
and business highlights for the fourth quarter and full year 2023
on Tuesday, Feb. 20 at 9 a.m.,
ET. The company will issue a news release detailing its
results before the market opens that same day.
The conference call will be hosted by Joe Woody, chief executive officer, and
Michael Greiner, senior vice
president and chief financial officer.
To join the live conference call, dial 877-240-5772 in the
United States. A simultaneous
webcast of the call and a related presentation will be accessible
via the Investors section of the Avanos Medical
website, https://avanos.investorroom.com/.
A replay of the conference call will be available Feb.
20 at noon ET by dialing 877-344-7529 in the
United States and entering passcode 5134094. It will be
available for one week. A replay of the webcast also will be
accessible in the Investors section of the website,
approximately one hour following the completion of the conference
call.
About Avanos Medical, Inc.
Avanos Medical (NYSE: AVNS) is a medical technology company focused
on delivering clinically superior medical device solutions that
will help patients get back to the things that matter.
Headquartered in Alpharetta,
Georgia, Avanos is committed to addressing some of today's
most important healthcare needs, including providing a vital
lifeline for nutrition to patients from hospital to home, and
reducing the use of opioids while helping patients move from
surgery to recovery. Avanos develops, manufactures, and markets its
recognized brands globally and holds leading market positions in
multiple product categories. For more information,
visit www.avanos.com and follow Avanos Medical on Twitter
(@AvanosMedical), LinkedIn and Facebook.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/avanos-medical-inc-to-webcast-conference-call-discussing-fourth-quarter-and-full-year-2023-financial-results-302061271.html
SOURCE Avanos Medical